Informing Spectroscopists for Over 40 Years


  • Shimadzu Scientific Instruments have released the MALDI-8020 benchtop MALDI-TOF mass spectrometer.

  • bioMérieux’s VITEK® MS MALDI-TOF MS system has been cleared by the US FDA for the expanded identification of mycobacteria, Nocardia and moulds.

  • This is a system for pharmaceutical label-free ultra-high-throughput screening (UHTS) for primary screens of millions of compounds.

  • Robotic system to pick bacterial colonies and deposit them on MALDI target plates.

  • Becton, Dickinson and Company has announced the global distribution of a complete portfolio of products for mass spectrometry that provides high-speed and high-confidence identification of pathogens in clinical laboratories.

  • Analytik Jena and Bruker Daltonics develop a new ultra-high throughput screening product for biopharmaceutical labs.

  • Bruker’s rapifleX MALDI-ToF/ToF system has new ToF/ToF optics and smartbeam 10 kHz laser technology.

  • JEOL USA have introduced of the company’s first commercially available MALDI-ToF mass spectrometer, the JEOL JMS-S3000 SpiralTOF. The SpiralTOF has new ToF ion optics with an extended flight length in a compact footprint, delivering a resolving power of greater than 60,000 (FWHM) over a wide mass range of m/z 10–30,000

  • Bruker has announced a novel MALDI molecular imaging system based on the high performance of the solariX FTMS. The new MALDI-solariX combines the extreme analytical performance of the solariX FTMS (resolving power > 1,000,000 at m/z400 at 7.0 tesla field strength) with a robust and highly sensitive MALDI source to provide an unrivalled platform for high performance molecular imaging of small molecules (e.g. drug, metabolites, lipids) in tissue.